Aviance Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,068
Closed -$1.51M 196
2016
Q3
$1.51M Buy
9,068
+487
+6% +$82.4K 0.04% 177
2016
Q2
$1.31M Buy
8,581
+858
+11% +$133K 0.04% 181
2016
Q1
$1.16M Buy
7,723
+1,021
+15% +$152K 0.04% 165
2015
Q4
$1.09M Buy
6,702
+2,079
+45% +$327K 0.04% 158
2015
Q3
$639K Buy
4,623
+4,523
+4,523% +$713K 0.02% 179
2015
Q2
$15K Buy
+100
New +$16K 0.02% 35
2014
Q1
Sell
-50
Closed -$6K 272
2013
Q4
$6K Hold
50
﹤0.01% 378
2013
Q3
$6K Buy
+50
New +$5.42K ﹤0.01% 357

Other funds holding AMGN

Aviance Capital Management's AMGN Position: Q4 2016 in Review

Aviance Capital Management sold out of Amgen (AMGN) in Q4 2016, closing a stake of 9,068 shares — an estimated $1.51M sold.

Aviance Capital Management first reported a position in AMGN in Q3 2013 and held it in 8 quarters. The position peaked at $1.51M in Q3 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Aviance Capital Management reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Aviance Capital Management sold 9,068 Amgen shares in Q4 2016, an estimated $1.51M.
  • Aviance Capital Management first reported a position in Amgen in Q3 2013 and held it in 8 quarters.
  • Aviance Capital Management's Amgen position peaked at $1.51M in Q3 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Aviance Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.